How Are State-Run Psilocybin Therapy Programs Going? - Science Friday Recap

Podcast: Science Friday

Published: 2026-02-17

Duration: 19 minutes

Guests: Alejandro Alonso Galva, Dr. Stacy Fischer

Summary

State-run psilocybin therapy programs in Oregon and Colorado are gaining traction, offering insights into their effectiveness and challenges. The episode explores the nuances of these programs, including accessibility, costs, and ongoing research.

What Happened

Psilocybin therapy, legalized for supervised medical use in Oregon and Colorado, is explored in this episode. Alejandro Alonso Galva describes the varying atmospheres of healing centers, which range from clinical settings to spa-like environments, depending on client preferences. He outlines the multi-step process of therapy sessions, which includes a screening, preparation, and the guided psilocybin experience, all under the supervision of a licensed facilitator.

Cost remains a significant barrier to accessibility, with the full therapy course costing thousands of dollars, not covered by insurance or Medicaid. This financial hurdle has led to creative solutions like group sessions to reduce costs. Alejandro notes that while Oregon has seen some clinics close, Colorado's introduction of micro healing center licenses aims to sustain operations with lower overheads.

Safety data collection is emphasized, with new laws mandating that health departments report outcomes. This is crucial for assessing psilocybin's effectiveness in treating conditions like PTSD and addiction. Alejandro mentions that while anecdotal evidence is promising, rigorous data is needed to validate these claims.

Flora Lichtman then interviews Dr. Stacy Fischer, who is co-leading the largest clinical trial on psilocybin for anxiety in advanced cancer patients. Fischer recounts a poignant story of a young cancer patient, which inspired her research into psilocybin's potential to ease existential distress.

The trial, now in its fourth year, has recruited more patients than any previous study focused on cancer-related anxiety. Preliminary feedback suggests profound emotional experiences, with some patients describing enhanced feelings of love and connection.

However, not all patients have positive experiences, highlighting the importance of psychological readiness and proper expectations. Dr. Fischer stresses the need for careful screening and the role of therapy in enhancing psilocybin's benefits.

The episode concludes with a discussion on the need for standardization in dosage and therapy protocols to ensure safety and efficacy as more states consider legalizing psilocybin therapy.

Key Insights

• In Oregon and Colorado, psilocybin therapy takes on diverse forms, from clinical to spa-like environments, tailoring the healing atmosphere to client preferences, which challenges the one-size-fits-all approach in mental health treatments.
• The high cost of psilocybin therapy, reaching thousands of dollars and not covered by insurance, pushes some clinics to offer group sessions as a creative solution to make these transformative experiences more accessible.
• Colorado's micro healing center licenses aim to keep psilocybin therapy sustainable by allowing smaller operations to thrive with lower overheads, contrasting with Oregon's struggle where some clinics have closed due to high costs.
• Dr. Stacy Fischer's clinical trial on psilocybin for anxiety in cancer patients has recruited more participants than any prior study, driven by initial findings of profound emotional experiences, though psychological readiness remains critical to avoid negative outcomes.

Key Questions Answered

What are the costs associated with psilocybin therapy in Colorado?

Psilocybin therapy in Colorado can cost thousands of dollars for a full course of treatment. These costs are not covered by insurance or Medicaid, making it a financial hurdle for many who could benefit from the therapy.

How are psilocybin therapy trials helping cancer patients at CU School of Medicine?

Dr. Stacy Fischer's trial at CU School of Medicine is exploring psilocybin's potential to alleviate anxiety and existential distress in advanced cancer patients. Early feedback indicates significant emotional benefits, though not all experiences are positive.

What are the challenges faced by psilocybin clinics in Oregon and Colorado?

Psilocybin clinics face high operational costs, leading to closures in Oregon. Colorado's micro healing center licenses aim to lower these costs, but accessibility remains a challenge due to therapy not being covered by insurance.